These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33435224)

  • 1. Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of
    Shah RG; Merlin MA; Adant S; Zine-Eddine F; Beauregard JM; Shah GM
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33435224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing the anti-tumour activity of
    Cullinane C; Waldeck K; Kirby L; Rogers BE; Eu P; Tothill RW; Hicks RJ
    Sci Rep; 2020 Jun; 10(1):10196. PubMed ID: 32576907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Therapeutic Response to Treatment with a 177Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical Models.
    Dalm SU; Nonnekens J; Doeswijk GN; de Blois E; van Gent DC; Konijnenberg MW; de Jong M
    J Nucl Med; 2016 Feb; 57(2):260-5. PubMed ID: 26514177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to
    Waldeck K; Van Zuylekom J; Cullinane C; Gulati T; Simpson KJ; Tothill RW; Blyth B; Hicks RJ
    Theranostics; 2023; 13(14):4745-4761. PubMed ID: 37771787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide Receptor Radionuclide Therapy with
    Cullinane C; Jeffery CM; Roselt PD; van Dam EM; Jackson S; Kuan K; Jackson P; Binns D; van Zuylekom J; Harris MJ; Hicks RJ; Donnelly PS
    J Nucl Med; 2020 Dec; 61(12):1800-1805. PubMed ID: 32414949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of
    Purohit NK; Shah RG; Adant S; Hoepfner M; Shah GM; Beauregard JM
    Oncotarget; 2018 May; 9(37):24693-24706. PubMed ID: 29872498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model.
    Sharma R; Earla B; Baidoo KE; Zeiger MA; Madigan JP; Escorcia FE; Sadowski SM
    Mol Cancer Ther; 2023 Sep; 22(9):1052-1062. PubMed ID: 37487000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to mice.
    Klomp MJ; van den Brink L; van Koetsveld PM; de Ridder CMA; Stuurman DC; Löwik CWGM; Hofland LJ; Dalm SU
    Life Sci; 2023 Dec; 334():122173. PubMed ID: 37907154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of [
    Njotu FN; Ketchemen JP; Tikum AF; Babeker H; Gray BD; Pak KY; Uppalapati M; Fonge H
    J Nucl Med; 2024 Apr; 65(4):533-539. PubMed ID: 38485273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours.
    Adant S; Shah GM; Beauregard JM
    Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):907-921. PubMed ID: 31492995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide receptor chemoradionuclide therapy in small cell carcinoma: from bench to bedside.
    Lewin J; Cullinane C; Akhurst T; Waldeck K; Watkins DN; Rao A; Eu P; Mileshkin L; Hicks RJ
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):25-32. PubMed ID: 25125202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Effect of Multiple Histone Deacetylase Inhibitors on SSTR2 Expression and [
    Klomp MJ; Dalm SU; van Koetsveld PM; Dogan F; de Jong M; Hofland LJ
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage peptide receptor radionuclide therapy with [
    van der Zwan WA; Brabander T; Kam BLR; Teunissen JJM; Feelders RA; Hofland J; Krenning EP; de Herder WW
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):704-717. PubMed ID: 30267116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-centre experience with peptide receptor radionuclide therapy for neuroendocrine tumours (NETs): results using a theranostic molecular imaging-guided approach.
    Gordon S; Chan DLH; Bernard EJ; Eslick ME; Willowson KP; Roach PJ; Engel AF; Maher R; Clarke SJ; Agarwal V; Yasmin L; De Silva M; Mascall S; Conner A; Nevell D; Pavlakis N; Bailey DL
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7717-7728. PubMed ID: 37004598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog
    Zhang J; Wang H; Jacobson O; Cheng Y; Niu G; Li F; Bai C; Zhu Z; Chen X
    J Nucl Med; 2018 Nov; 59(11):1699-1705. PubMed ID: 29653971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy.
    Evans JS; Beaumont J; Braga M; Masrour N; Mauri F; Beckley A; Butt S; Karali CS; Cawthorne C; Archibald S; Aboagye EO; Sharma R
    Eur J Cancer; 2022 Nov; 176():110-120. PubMed ID: 36208569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of SSTR2 Expression in SI-NETs and Relation to Overall Survival after PRRT.
    Elf AK; Johanson V; Marin I; Bergström A; Nilsson O; Svensson J; Wängberg B; Bernhardt P; Elias E
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining [
    Rauch H; Kitzberger C; Janghu K; Hawarihewa P; Nguyen NT; Min Y; Ballke S; Steiger K; Weber WA; Kossatz S
    Eur J Nucl Med Mol Imaging; 2024 Jul; ():. PubMed ID: 39023784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Clinical Guide to Peptide Receptor Radionuclide Therapy with
    Becx MN; Minczeles NS; Brabander T; de Herder WW; Nonnekens J; Hofland J
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic Neuroendocrine Tumor with Extensive Bone Marrow Involvement at Diagnosis: Evaluation of Response and Hematological Toxicity Profile of PRRT with (177)Lu-DOTATATE.
    Basu S; Ranade R; Thapa P
    World J Nucl Med; 2016; 15(1):38-43. PubMed ID: 26912977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.